Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
Holding XTLB?
Track your performance easily
XTLB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.75 - $4.99
Previous Close$1.75
Volume1.11K
Average Volume (3M)41.63K
Market Cap
$23.15M
Enterprise Value$21.14M
Total Cash (Recent Filing)$2.01M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Dec 05, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding5,449,061
10 Day Avg. Volume16,241
30 Day Avg. Volume41,635
Standard Deviation0.32
R-Squared0.04
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-18.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XTL Biopharmaceuticals Ltd. Sponsored ADR News
PremiumCompany Announcements
XTL Biopharmaceuticals Adjusts Shares, Eyes Expansion
PremiumCompany Announcements
XTL Biopharmaceuticals Resolves Dispute with Social Proxy
PremiumCompany Announcements
XTL Biopharmaceuticals Faces Financial Dispute After Acquisition
PremiumCompany Announcements
XTL Biopharmaceuticals Expands with AI Company Acquisition
PremiumCompany Announcements
XTL Biopharmaceuticals Announces Shareholder Meeting OutcomesPremiumCompany Announcements
XTL Biopharmaceuticals Announces Upcoming Shareholder Meeting
PremiumCompany Announcements
XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD.Ownership Overview
―
Insiders
0.07% Mutual Funds
1.59% Other Institutional Investors
98.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
XTLB FAQ
What was XTL Biopharmaceuticals Ltd. Sponsored ADR’s price range in the past 12 months?
XTL Biopharmaceuticals Ltd. Sponsored ADR lowest stock price was $0.75 and its highest was $4.99 in the past 12 months.
What is XTL Biopharmaceuticals Ltd. Sponsored ADR’s market cap?
Currently, no data Available
When is XTL Biopharmaceuticals Ltd. Sponsored ADR’s upcoming earnings report date?
XTL Biopharmaceuticals Ltd. Sponsored ADR’s upcoming earnings report date is Dec 05, 2023 which is 352 days ago.
How were XTL Biopharmaceuticals Ltd. Sponsored ADR’s earnings last quarter?
XTL Biopharmaceuticals Ltd. Sponsored ADR released its earnings results on May 31, 2023. The company reported -$0.169 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.169.
Is XTL Biopharmaceuticals Ltd. Sponsored ADR overvalued?
According to Wall Street analysts XTL Biopharmaceuticals Ltd. Sponsored ADR’s price is currently Overvalued.
Does XTL Biopharmaceuticals Ltd. Sponsored ADR pay dividends?
XTL Biopharmaceuticals Ltd. Sponsored ADR does not currently pay dividends.
What is XTL Biopharmaceuticals Ltd. Sponsored ADR’s EPS estimate?
XTL Biopharmaceuticals Ltd. Sponsored ADR’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XTL Biopharmaceuticals Ltd. Sponsored ADR have?
XTL Biopharmaceuticals Ltd. Sponsored ADR has 12,543,432 shares outstanding.
What happened to XTL Biopharmaceuticals Ltd. Sponsored ADR’s price movement after its last earnings report?
XTL Biopharmaceuticals Ltd. Sponsored ADR reported an EPS of -$0.169 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of XTL Biopharmaceuticals Ltd. Sponsored ADR?
Currently, no hedge funds are holding shares in XTLB
---
XTL Biopharmaceuticals Ltd. Sponsored ADR Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
XTL Biopharmaceuticals Ltd. Sponsored ADR
XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
---
Technical Analysis
---